IMP3 Expression Can Distinguish Hepatocellular Carcinoma from Hepatocellular Adenoma

被引：0
|
作者：
Wagner, D. G.
Yang, Q.
McMahon, L. A.
Spaulding, B. O.
Wang, H. L.
Xu, H.
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1472
引用
收藏
页码：325A / 325A
页数：1
相关论文
共 50 条
  • [1] IMP3 Expression Can Distinguish Hepatocellular Carcinoma from Hepatocellular Adenoma
    Wagner, D. G.
    Yang, Q.
    McMahon, L. A.
    Spaulding, B. O.
    Wang, H. L.
    Xu, H.
    MODERN PATHOLOGY, 2009, 22 : 325A - 325A
  • [2] IMP3, an Oncofetal Protein, Is a Useful Diagnostic Biomarker for Hepatocellular Carcinoma.
    Kamionek, M.
    Jiang, Z.
    Chu, P.
    Rock, K.
    Kandil, D.
    MODERN PATHOLOGY, 2011, 24 : 155A - 155A
  • [3] Aberrantly Expressed tRNA-Val Fragments Can Distinguish Canine Hepatocellular Carcinoma from Canine Hepatocellular Adenoma
    Hashimoto, Saki
    Hasan, M. D. Nazmul
    Arif, Mohammad
    Nozaki, Nobuhiro
    Husna, Al Asmaul
    Furusawa, Yu
    Sogawa, Takeshi
    Takahashi, Kaori
    Kuramoto, Tomohide
    Noguchi, Aki
    Takahashi, Masashi
    Yamato, Osamu
    Rahman, Md Mahfuzur
    Miura, Naoki
    GENES, 2024, 15 (08)
  • [4] IMP3, an Oncofetal Protein, Is a Useful Diagnostic Biomarker for Hepatocellular Carcinoma.
    Kamionek, M.
    Jiang, Z.
    Chu, P.
    Rock, K.
    Kandil, D.
    LABORATORY INVESTIGATION, 2011, 91 : 155A - 155A
  • [5] Elucidating transcriptional roles in the regulation of IMP3 expression for developing promoter-driven targeted therapy in hepatocellular carcinoma
    Wang, W.
    Liu, Y.
    Yen, C.
    HUMAN GENE THERAPY, 2019, 30 (11) : A59 - A60
  • [6] IMP3 Expression Can Distinguish Cholangiocarcinomas and Metastatic Pancreactic Ductal Carcinomas from Benign Bile Duct Lesions
    Wagner, D. G.
    Yang, Q.
    McMahon, L. A.
    Spaulding, B. O.
    Wang, H. L.
    Xu, H.
    LABORATORY INVESTIGATION, 2009, 89 : 324A - 325A
  • [7] Noncirrotic hepatocellular carcinoma derivated from hepatocellular adenoma
    Gonzalez Serrano, M. T.
    Sanchez Frias, M. E.
    Fuentes Vaamonde, H.
    Centeno Haro, M.
    Salvatierra Cuenca, J.
    Medina Perez, M.
    VIRCHOWS ARCHIV, 2015, 467 : S230 - S230
  • [8] IMP3 Expression Can Distinguish Cholangiocarcinomas and Metastatic Pancreactic Ductal Carcinomas from Benign Bile Duct Lesions
    Wagner, D. G.
    Yang, Q.
    McMahon, L. A.
    Spaulding, B. O.
    Wang, H. L.
    Xu, H.
    MODERN PATHOLOGY, 2009, 22 : 324A - 325A
  • [9] IMP3 Expression Differentiates Ovarian Serous from Endometrioid Carcinoma
    Goodman, S.
    Lu, D.
    MODERN PATHOLOGY, 2012, 25 : 273A - 273A
  • [10] Oncofetal Protein IMP3, a Diagnostic Biomarker To Distinguish Microcystic Adnexal Carcinoma from Syringoma
    Cornejo, K.
    Deng, A.
    LABORATORY INVESTIGATION, 2012, 92 : 118A - 118A
12345